KRT18 and metabolic dysfunction-associated steatotic liver disease: In this prospective study, we aimed at assessing FGF21, CK18 M30 and M65ED levels during different stages in the spectrum of NAFLD and evaluating their respective role in early identification and predicting the prognosis of NAFLD patients to investigate their clinical significance.